Metronidazole Intravenous Iv 500 mg/100 mL, 1 g/100 mL Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV)
Available Strengths: 500 mg/100 mL, 1 g/100 mL
Reference Brands: Flagyl(US), Metronidazol-Darnytsia (Ukraine)
Category: Medical Aid
Metronidazole IV inhibits bacterial and protozoal DNA synthesis by disrupting nucleic acid structures. It provides rapid, effective treatment for severe anaerobic infections, abscesses, and protozoal diseases. Benefits include quick bacterial eradication, good tissue penetration, and use in critical care when oral therapy isn’t feasible.
Product Description:
Metronidazole IV is approved in the EU and US for serious anaerobic bacterial and protozoal infections. In the EU, brands like Flagyl IV are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for metronidazole IV, ensuring adherence to European and US standards for safe, effective antimicrobial therapy in severe infections.
Metronidazole Intravenous Iv — third party manufacturing & bulk supply
Metronidazole Intravenous Iv 500 mg/100 mL, 1 g/100 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Metronidazole Intravenous Iv listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Metronidazole Intravenous Iv →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Metronidazole intravenous IV is used to treat serious infections caused by anaerobic bacteria and certain parasites. It is commonly prescribed for intra-abdominal infections, gynecological infections, skin and soft tissue infections, bone and joint infections, and septicemia caused by susceptible organisms. It is also used in the treatment of infections such as bacterial vaginosis, trichomoniasis, and amoebiasis when oral therapy is not suitable. The IV formulation is typically administered in hospital settings for moderate to severe infections.
Metronidazole intravenous IV contains the active pharmaceutical ingredient metronidazole, a synthetic nitroimidazole antimicrobial agent. It works by entering microbial cells and disrupting DNA synthesis, which leads to the death of susceptible bacteria and protozoa.
Metronidazole intravenous IV is marketed under several trade names worldwide including Flagyl IV, Metronidazole Injection, Metrogyl IV, and other generic metronidazole infusion brands depending on the manufacturer and region.
One of the well-known brands, Flagyl IV, was originally marketed by Pfizer. Today, metronidazole IV formulations are manufactured globally by many pharmaceutical companies including Sanofi, Fresenius Kabi, and Baxter International along with several generic manufacturers.
The generic name of Metronidazole intravenous IV is metronidazole.
Common brand names include Flagyl IV, Metrogyl IV, Metronidazole Injection, and other regional generic brands.
Metronidazole intravenous IV is manufactured in several countries including the United States, India, China, and multiple European countries by various pharmaceutical companies supplying hospital and clinical markets worldwide.
Related Products
Indocyanine Green
Strength:
25 mg
Form: Injection
Reference Brands: IC-Green (USA), Verdye (USA/EU)
View Details
Hexaminolevulinate Hydrochloride
Strength:
100 mg , 85 mg
Form: Injection
Reference Brands: Cysview (USA), Hexvix (EU)
View Details
Indigotindisulfonate Sodium
Strength:
20 mg/mL, 40 mg/mL
Form: Injection
Reference Brands: Indigo Carmine ((USA), Bludigo (USA)
View Details
Lofexidine Hydrochloride
Strength:
0.18 mg
Form: Tablets
Reference Brands: Lucemyra (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
